Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to -$6.4 million.

  • Angiodynamics' Net Income towards Common Stockholders rose 4086.42% to -$6.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$27.7 million, marking a year-over-year increase of 8766.92%. This contributed to the annual value of -$34.0 million for FY2025, which is 8156.05% up from last year.
  • As of Q4 2025, Angiodynamics' Net Income towards Common Stockholders stood at -$6.4 million, which was up 4086.42% from -$10.9 million recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Net Income towards Common Stockholders ranged from a high of $45.9 million in Q3 2023 and a low of -$187.7 million during Q1 2024
  • Over the past 5 years, Angiodynamics' median Net Income towards Common Stockholders value was -$9.0 million (recorded in 2022), while the average stood at -$16.9 million.
  • As far as peak fluctuations go, Angiodynamics' Net Income towards Common Stockholders soared by 45284.53% in 2023, and later tumbled by 187929.36% in 2024.
  • Quarter analysis of 5 years shows Angiodynamics' Net Income towards Common Stockholders stood at -$8.4 million in 2021, then fell by 1.62% to -$8.5 million in 2022, then plummeted by 242.3% to -$29.0 million in 2023, then soared by 63.03% to -$10.7 million in 2024, then surged by 40.86% to -$6.4 million in 2025.
  • Its last three reported values are -$6.4 million in Q4 2025, -$10.9 million for Q3 2025, and -$6.0 million during Q2 2025.